English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells Journal article
Biomedicine and Pharmacotherapy, 2022,Volume: 151
Authors:  Chen, Shaokui;  Li, Ruixin;  Chen, Yibo;  Chou, Chon Kit;  Zhang, Zhexuan;  Yang, Yang;  Liao, Ping;  Wang, Qingqing;  Chen, Xin
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/08/02
Cancer Immunotherapy  cd4+foxp3+ Regulatory t Cells  Cpg Oligodeoxynucleotide  Scutellarin  Tumor Necrosis Factor  Tumor Necrosis Factor Receptor Ii  
Use of scutellarin in a medicament and a modulator for preventing or treating diseases, medicament, and modulator Patent
专利类型: 发明专利Invention,
Authors:  Xin Chen;  Ruixin Li;  Shaokui Chen
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date：2022/08/30
TNFR2-expressing CD4(+) Foxp3(+) regulatory T cells in cancer immunology and immunotherapy Book chapter
出自: Cancer Immunotherapy:Elsevier, 2019, 页码: 101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite |  | TC[WOS]:12 TC[Scopus]:10 | Submit date：2019/05/08
TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy Book chapter
出自: Progress in Molecular Biology and Translational Science:ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA, 2019, 页码: 101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite |  | TC[WOS]:12 TC[Scopus]:10 | Submit date：2020/05/05
Regulatory t Cells  Tumor Necrosis Factor Receptor Type 2  Cancer  Immunotherapy  Tumor Necrosis Factor  
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy Other
2019-01-01
Authors:  He, J.;  Li, Ruixin;  Chen, Yibo;  Hu, Yuanjia;  Chen, Xin
Favorite |  | TC[WOS]:12 TC[Scopus]:10 | Submit date：2022/05/23
Cancer  Immunotherapy  Regulatory T cells  Tumor necrosis factor  Tumor necrosis factor receptor type 2  
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents Journal article
FRONTIERS IN IMMUNOLOGY, 2018,Volume: 9
Authors:  Zou, Huimin;  Li, Ruixin;  Hu, Hao;  Hu, Yuanjia;  Chen, Xin
Favorite |  | TC[WOS]:32 TC[Scopus]:30 | Submit date：2018/10/30
Tnf Receptor Type Ii  Regulatory t Cells  Tnf Receptor Type Ii Agonists  Tnf Receptor Type Ii Antagonists  Immunotherapy